[The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].


AIM to investigate the molecular mechanisms and morphological substrate of reduced uterine leiomyoma in patients receiving the selective progesterone receptor modulator (SPRM) ulipristal acetate for 3 months, by estimating the immunohistochemical expression of the markers steroid receptor coactivator 1 (SRC-1), nuclear receptor corepressor 1 (NCoR-1), ER… (More)
DOI: 10.17116/patol201779319-26